Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program. - Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM (American journal of obstetrics and gynecology, 2021)